The entire legal marijuana sector had a mighty good 2018.
We saw California, with a population of nearly 40 million people, begin sales of fully legalized marijuana for recreational use.
Over the summer, the FDA approved the use of a cannabis-derived drug, Epidiolex, for the first time. In the fall, the rollback of cannabis prohibition hit the big time across Canada. All the while, here at home, states took it upon themselves to extend the legalization of cannabis, whether for medical or recreational use, across the United States.
And just last month, the cultivation and sale of a type of cannabis plant – hemp – and products derived from it became legal across the United States with the passage of the Farm Bill.
But if we’re being frank, all of this will pale in comparison to what’s coming in 2019.
In fact, we believe one segment – worth around $2 billion today – will outperform everything we saw last year combined…
About the Author
Greg Miller started working on Wall Street in September, 1987, just a month before the “Black Monday” stock market crash.
During his career there, he became an expert in just about every kind of publicly traded security – from blue-chip and small-cap stocks to municipals, junk bonds, and derivatives. As a portfolio manager, Greg was responsible for over $500 million of assets in mutual funds and insurance company accounts.
After leaving the Street, he designed a successful options trading strategy and made lucrative tech investments for a financial publication. He has also helped develop new products and worked with other editors to hone their strategies. He’s always been dedicated to deep, fundamental research – and he always will be – because he believes buying the very best companies at the right price is the best way to amass wealth in the stock market.
This post is from MoneyMorning. We encourage our readers to continue reading the full article from the original source here.